UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

This week we break down the big reveals from the 2026 New York Auto Show. Greg Migliore is joined by Kyle Patrick from New York to discuss the Hyundai Boulder concept, VW Atlas, Subaru Getaway, ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...